amputations in adult civilians, and the incidence was similar compared with traumatic amputations. Postamputation pain is a common occurrence in patients who undergo amputation, leading to a significant burden on the health care system, particularly in the Veterans Affairs system. Current literature suggests that HO may be an under-reported mechanism by which patients have postsurgical stump pain, even in atraumatic amputations. Surgical excision has been shown to be highly effective in managing postamputation pain associated with HO.
IP131. Preoperative Indicators for Venous Complications Associated With Implanted Ports
Madeline Heald, Robert Netzley, Dennis Wright, Loren Masterson, Jill Zink. Cleveland Clinic Akron General, Akron, Ohio
Objective: Central venous ports have been a critical part of prolonged venous access for a variety of different indications, including chemotherapy, nutritional support, repeated administration of blood products, and frequent blood draws. Complications of these ports cause delays in treatment, increased morbidity, and increased medical expenses. The ability to identify patients at risk for complications can allow prevention and alternative therapies, resulting in improved outcomes, patient care, and satisfaction. The aim of this study was to identify preoperative indicators associated with complications from implanted central venous ports.
Methods: A retrospective review of 1105 charts was performed during 15 years (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . Evaluation of placement site, indication for procedure, and diagnostic laboratory values were reviewed to determine their significance related to port complications.
Results: A total of 1105 ports were placed (938 arm and 165 chest). The overall complication rate (ie, infection, thrombosis, erosion, and mechanical failure) was 12.3%, with 94 patients (8.5%) developing an infection and 29 patients (2.6%) developing deep venous thrombosis or thrombosis. There was no significant difference in overall complication rate with respect to the implantation site (P ¼ .442). Of the ports placed, 294 had a preprocedure white blood cell (WBC) count within 5 days of port placement; 40 patients had a WBC count of 4.4 Â 10 3 cells/mL and 88 had a WBC count of 9.7 Â 10 3 cells/mL. A WBC count outside the normal range (4.4 Â 10 3 or 9.7 Â 10 3 cells/mL) had a significantly higher complication rate (P ¼ .024). Ports placed for a nonmalignant indication (eg, anemia, depression) were associated with an increased complication rate (P < .001). Ports placed for breast malignant neoplasms had a lower risk of port complication.
Conclusions:
We have identified multiple factors that appear to increase the risk for development of a complication from an implanted central venous port. WBC count appears to have a significant association with complication rates after implantation. Both infection and thrombosis rates were increased with WBC count outside the normal limit. If possible, one should consider delaying port placement until the WBC count normalizes, using alternative venous access to decrease serious complications. Ports placed for a nonmalignant indication had a significantly increased complication rate. Further evaluation is needed to determine whether alternative access will improve outcomes in this group of patients. 
